Abstract
Parenteral amiodarone is used frequently in acutely ill patients, but it can be associated with hepatotoxicity. We present a case of fatal fulminant hepatic failure attributable to intravenous amiodarone. We review the literature and explore possible reasons for the severe reaction seen in our patient.
Get full access to this article
View all access options for this article.
